Holen Sie sich die Stockscreener-App
34.41
6.66%
2.15
Schlusskurs vom Vortag:
$32.26
Offen:
$32.58
24-Stunden-Volumen:
34,271
Relative Volume:
4.31
Marktkapitalisierung:
$135.51M
Einnahmen:
$17,000
Nettoeinkommen (Verlust:
$-23.87M
KGV:
-11.03
EPS:
-3.12
Netto-Cashflow:
$-22.03M
1W Leistung:
+33.06%
1M Leistung:
+22.94%
6M Leistung:
+107.41%
1J Leistung:
+106.05%
1-Tages-Spanne:
$30.30
$35.23
1-Wochen-Bereich:
$25.98
$35.23
52-Wochen-Spanne:
$13.15
$35.23
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Firmenname
Vtv Therapeutics Inc
Sektor
Branche
Telefon
336-841-0300
Adresse
3980 PREMIER DR, HIGH POINT, NC
Vergleichen Sie VTVT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
34.41 | 127.04M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-19 | Eingeleitet | BTIG Research | Buy |
| 2019-05-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-04-10 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Eingeleitet | Northland Capital | Outperform |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-09-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-24 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-08-24 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten
Alzheimer’s Disease Market in the 7MM is USD 5,048 million in 2025, analyses DelveInsight - The Globe and Mail
Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect? - MSN
Big Money Moves: Why vTv Therapeutics Inc stock remains a top recommendation - BỘ NỘI VỤ
vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Above Fifty Day Moving AverageHere's What Happened - MarketBeat
Why vTv Therapeutics Inc. stock remains a top recommendationM&A Rumor & High Accuracy Swing Trade Signals - Newser
What makes vTv Therapeutics Inc. (5VT0) stock appealing to growth investorsWeekly Profit Summary & Consistent Income Trade Ideas - Newser
How vTv Therapeutics Inc. (5VT0) stock moves in volatile trading sessionsJuly 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - Newser
Can vTv Therapeutics Inc. (5VT0) stock hit consensus price targetsMarket Risk Analysis & Long-Term Safe Investment Ideas - Newser
Why vTv Therapeutics Inc. stock is a must watch in 20252025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Is vTv Therapeutics Inc. stock resilient to inflationSell Signal & Stock Market Timing Techniques - Newser
How dovish Fed policy supports vTv Therapeutics Inc. (5VT0) stockTrade Ideas & Free Verified High Yield Trade Plans - Newser
Published on: 2025-12-03 00:26:57 - Newser
Liquidity Mapping Around (VTVT) Price Events - news.stocktradersdaily.com
What technical patterns form on vTv Therapeutics Inc. (5VT0) stock chartsQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Here's Why We're Not Too Worried About vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Situation - Sahm
Will vTv Therapeutics Inc. (5VT0) stock attract long term capital inflowsJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
Why analysts remain bullish on vTv Therapeutics Inc. stock2025 Top Gainers & AI Enhanced Trading Alerts - Newser
Tangible book value per share of vTv Therapeutics, Inc. Class A – SWB:5VT0 - TradingView
Is vTv Therapeutics Inc a good long term investmentEarnings Call Summaries & Fast Growing Trading Ideas - earlytimes.in
What drives vTv Therapeutics Inc stock priceTake Profit Strategies & Exceptional Growth Portfolio - earlytimes.in
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above 50-Day Moving AverageHere's Why - MarketBeat
[EFFECT] vTv Therapeutics Inc. SEC Filing - Stock Titan
Why (VTVT) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
vTv Therapeutics (NASDAQ:VTVT) Raised to Strong-Buy at BTIG Research - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Upgraded at BTIG Research - Defense World
BTIG Research Initiates Coverage on vTv Therapeutics (NASDAQ:VTVT) - MarketBeat
Is vTv Therapeutics Inc. (5VT0) stock included in top ETFs2025 Historical Comparison & Entry Point Strategy Guides - newser.com
Why retail investors favor vTv Therapeutics Inc. stock2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Will vTv Therapeutics Inc. (5VT0) stock beat international competitionBond Market & Long-Term Safe Investment Plans - newser.com
What makes vTv Therapeutics Inc. stock attractive to growth fundsPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Can vTv Therapeutics Inc. stock sustain market leadershipJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
How vTv Therapeutics Inc. (5VT0) stock benefits from digital adoptionShort Setup & Weekly Chart Analysis and Guides - newser.com
Will vTv Therapeutics Inc. (5VT0) stock justify high valuationJuly 2025 Gainers & Safe Capital Growth Stock Tips - newser.com
Has vTv Therapeutics Inc. found a price floorWatch List & Free Expert Verified Stock Movement Alerts - newser.com
BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛
BTIG Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
Will vTv Therapeutics Inc. stock deliver consistent dividends2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Can vTv Therapeutics Inc. (5VT0) stock attract ESG investmentsQuarterly Earnings Report & Weekly Consistent Profit Watchlists - newser.com
BTIG Initiates Coverage on vTv Therapeutics (VTVT) with a "Buy" Rating | VTVT Stock News - GuruFocus
Is vTv Therapeutics Inc. (5VT0) stock supported by strong fundamentalsQuarterly Trade Review & Weekly Market Pulse Updates - newser.com
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):